Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

ADAPTIMMUNE THERAPEUTICS PLC Active

Scientific & Education


Contact information


Unlock Company Insights Free Access

Get instant access to key company data, decision-maker contacts, and verified insights.

Start for Free now

Financial statements of ADAPTIMMUNE THERAPEUTICS PLC

According to ADAPTIMMUNE THERAPEUTICS PLC latest financial report submitted on 2024-12-31, the company has a Turnover of $178M, Gross-Profit of $178M while the Cash is $93M. Compared with the previous year, the company reported a Turnover increase of 99.8%, which is an equivalent of -177677000. At the same time, the Gross-Profit went down by 0.0%, or by 0.


Year:
2023 Not available
2022 Not available
2021 Not available
2020 Not available

Access 20 Years of Financial Data

Start for free
  • Reporting period

    12

  • Consolidated A/cs

    Y

  • Profit after Tax

    $ -70.8 million

  • Working Capital

    $ 123.6 million

Profit after Tax

ADAPTIMMUNE THERAPEUTICS PLC Business Credit Report

A Business Credit Report for ADAPTIMMUNE THERAPEUTICS PLC is available for instant download. The report will provide you with a credit score and credit limit recommendation for ADAPTIMMUNE THERAPEUTICS PLC, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

ADAPTIMMUNE THERAPEUTICS PLC

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

ADAPTIMMUNE THERAPEUTICS PLC Directors and key executives

ADAPTIMMUNE THERAPEUTICS PLC currently employs 410 people. Compared with the previous year, the company has reported a staff increase of 0%, which is an equivalent of 1 employees.
In order to view contact information, including emails and phone numbers for all the employees working at ADAPTIMMUNE THERAPEUTICS PLC and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

410

100%

1y growth

124%

2y growth

Management Level


28

Top

64

Middle

Employee Job Title Email Phone Country
Adrian Rawcliffe Director
****************@adaptimmune.com
- GB
C Sigal Director
*@adaptimmune.com
- GB
John Furey Director
-
- GB
John Furey Director
-
- GB
James Noble Director
-
- GB

Get direct emails & phone numbers for senior executives working at «ADAPTIMMUNE THERAPEUTICS PLC»

Download our chrome extension and enrich prospect profiles in seconds. Organize contacts into focus lists, send e-mails or embed leads into automated sequences straight off their Linkedin profile - without leaving the browser.

Install Free Browser Extension

ADAPTIMMUNE THERAPEUTICS PLC Ownership and Group Structure


Explore the Full Corporate Tree.

Uncover parent companies, subsidiaries, and global linkages

Start Free Now

ADAPTIMMUNE THERAPEUTICS PLC Shareholders and Ultimate Beneficial Owners (UBO)

There are currently 5 people with significant control at ADAPTIMMUNE THERAPEUTICS PLC. One of of major shareholders of ADAPTIMMUNE THERAPEUTICS PLC is EcoR1 Capital, LLC, which owns 27404070 ORDINARY shares, with a total value of 0 USD and Fidelity NASDAQ Composite Index Fund, which owns 139801 ORDINARY shares, with a total value of 139,801 USD and Harbor Disruptive Innovation Fund, which owns 129616 ORDINARY shares, with a total value of 129,616 USD and Harbor ETF Tr-Harbor Disruptive Innovation ETF, which owns 59073 ORDINARY shares, with a total value of 59,073 USD and Fidelity Enhanced Small Cap ETF, which owns 159861 ORDINARY shares, with a total value of 159,861 USD.


Name Quantity Share Type Value
EcoR1 Capital, LLC
27404070 ORDINARY 0 USD
Fidelity NASDAQ Composite Index Fund
139801 ORDINARY 139801 USD
Harbor Disruptive Innovation Fund
129616 ORDINARY 129616 USD
Harbor ETF Tr-Harbor Disruptive Innovation ETF
59073 ORDINARY 59073 USD
Fidelity Enhanced Small Cap ETF
159861 ORDINARY 159861 USD

See All Beneficial Owners & Shareholders

Unlock Full Access For Free

ADAPTIMMUNE THERAPEUTICS PLC competitors:

Top 5 similar companies of ADAPTIMMUNE THERAPEUTICS PLC are REVVITY DISCOVERY LIMITED, QUOTIENT SCIENCES LIMITED, CANCER RESEARCH TECHNOLOGY LIMITED, GENOMICS ENGLAND LIMITED, ROSLIN CELL THERAPIES LIMITED. View and export all the competitor list of ADAPTIMMUNE THERAPEUTICS PLC by upgrading your account here.


REVVITY DISCOVERY LIMITED


Revenue
25,401,000.0
Age
20 years
Employees
225
Industry
View Scientific & Education
Website
View https://horizon**************

QUOTIENT SCIENCES LIMITED


Revenue
74,270,000.0
Age
21 years
Employees
555
Industry
View Scientific & Education
Website
View http://quotientsciences.co************************

CANCER RESEARCH TECHNOLOGY LIMITED


Revenue
55,157,000.0
Age
43 years
Employees
281
Industry
View Scientific & Education
Website
View http://cancertec**************

GENOMICS ENGLAND LIMITED


Revenue
29,209,369.0
Age
12 years
Employees
481
Industry
View Scientific & Education
Website
View https://genomics**************

ROSLIN CELL THERAPIES LIMITED


Revenue
16,836,047.0
Age
10 years
Employees
204
Industry
View Scientific & Education
Website
View https://ros**********

View & Export ADAPTIMMUNE THERAPEUTICS PLC competitors:

Get the complete list with detailed profiles

Start For Free

ADAPTIMMUNE THERAPEUTICS PLC news & activities:


Turnover

ADAPTIMMUNE THERAPEUTICS PLC has submitted new account statements and has reported a turnover of $178M, a 99.8% decrease year-over-year.

uk.globaldatabase.com

2024-12-31

EBITDA

The ADAPTIMMUNE THERAPEUTICS PLC-based company said the adjusted EBITDA is now -$53M, compared with the previous year of -97040000.

uk.globaldatabase.com

2024-12-31

Employees

ADAPTIMMUNE THERAPEUTICS PLC number of employees has decreased by 0% compared with previous year and now represents a total number of 410.

uk.globaldatabase.com

2024-12-31

Stay Ahead with Real-Time Insights

Monitor key metrics and company activity

Start For Free

Frequently Asked Questions regarding ADAPTIMMUNE THERAPEUTICS PLC


Where is ADAPTIMMUNE THERAPEUTICS PLC registered office?

ADAPTIMMUNE THERAPEUTICS PLC is located at 60 Jubilee Avenue Milton Park, United Kingdom.

How can I contact ADAPTIMMUNE THERAPEUTICS PLC?

You can call ADAPTIMMUNE THERAPEUTICS PLC at the following number +441235******

What is the website of ADAPTIMMUNE THERAPEUTICS PLC?

ADAPTIMMUNE THERAPEUTICS PLC website is https://adaptimmune.com/

How many people work at ADAPTIMMUNE THERAPEUTICS PLC?

According to the latest account statement, there are currently 410 of employees working for ADAPTIMMUNE THERAPEUTICS PLC.

How much revenue does ADAPTIMMUNE THERAPEUTICS PLC make?

Based on the latest financial accounts submitted on 2024-12-31, the company made $178M for 2024, which went up by 99.8%.

What is ADAPTIMMUNE THERAPEUTICS PLC EBITDA?

For 2024, ADAPTIMMUNE THERAPEUTICS PLC has reported an EBITDA of -$53M, which went up by 84.26% compared to previous year.

What is the Business Credit Score of ADAPTIMMUNE THERAPEUTICS PLC and how reliable is the company?

In order to check the business credit score of ADAPTIMMUNE THERAPEUTICS PLC, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does ADAPTIMMUNE THERAPEUTICS PLC pay their invoices on time?

By requesting a Business Credit Report for ADAPTIMMUNE THERAPEUTICS PLC, you will be able to gain more insights about the ADAPTIMMUNE THERAPEUTICS PLC payment trends.

Who is the Ultimate Parent of the ADAPTIMMUNE THERAPEUTICS PLC?

Information about the ultimate beneficial ownership ADAPTIMMUNE THE************* of ADAPTIMMUNE THERAPEUTICS PLC is available when you order a business credit report.

Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.

Get Free API Access

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action